In cancer, the aberrant sialylation is closely related to elevated expression of sialyltransferases, including ST3Gal1, STGal4, ST6-Gal1 and ST8Sia2, and their products, especially Sialyl-Levisa,x epitopes that correlate with poor prognosis [84,85]. The gene discussed is CD82; the disease is cancer.